GUYER WILLIAM (Chief Development Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 6/3/2026ACC: 0001193125-26-256015
Officer· Chief Development Officer
Since Aug 2021
+1.75K
Net shares
Net buyer
$61.8K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.75K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+877.00
Price / share
$70.44
Trade value
$61.78K
% of position
39.3%
6/1/2026
2.23K→3.11K
Common Stock
Direct
Shares
+877.00
Price / share
—
Trade value
—
% of position
28.2%
6/1/2026
3.11K→3.98K
Total
Net shares
+1.75K
Net value
$61.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | A · Award | +877.00 | $70.44 | $61.78K | 39.3% | 2.23K | 3.11K |
| Common Stock Direct | 6/1/2026 | A · Award | +877.00 | — | — | 28.2% | 3.11K | 3.98K |
| Total | +1.75K | $61.78K | ||||||
Derivative Transactions0
No derivative transactions reported